227 related articles for article (PubMed ID: 31338570)
1. Ileostomy for steroid-resistant acute graft-versus-host disease of the gastrointestinal tract.
Turki AT; Bayraktar E; Basu O; Benkö T; Yi JH; Kehrmann J; Tzalavras A; Liebregts T; Beelen DW; Steckel NK
Ann Hematol; 2019 Oct; 98(10):2407-2419. PubMed ID: 31338570
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of intra-arterial steroid infusions in patients with steroid-resistant gastrointestinal acute graft-versus-host disease.
Nishimoto M; Koh H; Hirose A; Nakamae M; Nakane T; Hayashi Y; Okamura H; Yoshimura T; Koh S; Nanno S; Nakashima Y; Takeshita T; Yamamoto A; Sakai Y; Nishida N; Matsuoka T; Miki Y; Hino M; Nakamae H
Exp Hematol; 2015 Dec; 43(12):995-1000. PubMed ID: 26303639
[TBL] [Abstract][Full Text] [Related]
3. Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tract.
Ganetsky A; Frey NV; Hexner EO; Loren AW; Gill SI; Luger SM; Mangan JK; Martin ME; Babushok DV; Drobyski WR; Smith J; Timlin C; Freyer CW; Stadtmauer EA; Porter DL
Bone Marrow Transplant; 2019 Feb; 54(2):212-217. PubMed ID: 29795429
[TBL] [Abstract][Full Text] [Related]
4. Impact of Gut Colonization by Antibiotic-Resistant Bacteria on the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective, Single-Center Study.
Bilinski J; Robak K; Peric Z; Marchel H; Karakulska-Prystupiuk E; Halaburda K; Rusicka P; Swoboda-Kopec E; Wroblewska M; Wiktor-Jedrzejczak W; Basak GW
Biol Blood Marrow Transplant; 2016 Jun; 22(6):1087-1093. PubMed ID: 26900084
[TBL] [Abstract][Full Text] [Related]
5. Safety and Efficacy of Fecal Microbiota Transplantation for Grade IV Steroid Refractory GI-GvHD Patients: Interim Results From FMT2017002 Trial.
Zhao Y; Li X; Zhou Y; Gao J; Jiao Y; Zhu B; Wu D; Qi X
Front Immunol; 2021; 12():678476. PubMed ID: 34220825
[TBL] [Abstract][Full Text] [Related]
6. A Multicenter Study of Bacterial Blood Stream Infections in Pediatric Allogeneic Hematopoietic Cell Transplantation Recipients: The Role of Acute Gastrointestinal Graft-versus-Host Disease.
Satwani P; Freedman JL; Chaudhury S; Jin Z; Levinson A; Foca MD; Krajewski J; Sahdev I; Talekar MK; Gardenswartz A; Silverman J; Hayes M; Dvorak CC
Biol Blood Marrow Transplant; 2017 Apr; 23(4):642-647. PubMed ID: 28104513
[TBL] [Abstract][Full Text] [Related]
7. A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality.
MacMillan ML; Robin M; Harris AC; DeFor TE; Martin PJ; Alousi A; Ho VT; Bolaños-Meade J; Ferrara JL; Jones R; Arora M; Blazar BR; Holtan SG; Jacobsohn D; Pasquini M; Socie G; Antin JH; Levine JE; Weisdorf DJ
Biol Blood Marrow Transplant; 2015 Apr; 21(4):761-7. PubMed ID: 25585275
[TBL] [Abstract][Full Text] [Related]
8. Poor outcome in steroid-refractory graft-versus-host disease with antithymocyte globulin treatment.
Arai S; Margolis J; Zahurak M; Anders V; Vogelsang GB
Biol Blood Marrow Transplant; 2002; 8(3):155-60. PubMed ID: 11939605
[TBL] [Abstract][Full Text] [Related]
9. Acute Steroid-Refractory Gastrointestinal Graft-Versus-Host Disease Is Not Associated With Significant Differences in Gut Taxonomic Composition Compared to Steroid-Sensitive Gastrointestinal Graft-Versus-Host Disease Immediately Before Onset of Disease.
Zeng K; Brewster R; Kang JB; Tkachenko E; Brooks E; Bhatt AS; Fodor AA; Andermann TM
Transplant Cell Ther; 2024 Feb; 30(2):237.e1-237.e9. PubMed ID: 37944820
[TBL] [Abstract][Full Text] [Related]
10. Early antithymocyte globulin therapy improves survival in patients with steroid-resistant acute graft-versus-host disease.
MacMillan ML; Weisdorf DJ; Davies SM; DeFor TE; Burns LJ; Ramsay NK; Wagner JE; Blazar BR
Biol Blood Marrow Transplant; 2002; 8(1):40-6. PubMed ID: 11858189
[TBL] [Abstract][Full Text] [Related]
11. Treating Steroid Refractory Intestinal Acute Graft-vs.-Host Disease With Fecal Microbiota Transplantation: A Pilot Study.
Qi X; Li X; Zhao Y; Wu X; Chen F; Ma X; Zhang F; Wu D
Front Immunol; 2018; 9():2195. PubMed ID: 30319644
[TBL] [Abstract][Full Text] [Related]
12. Outcome of gastrointestinal graft-versus-host disease according to the treatment response.
Tamaki M; Nakasone H; Misaki Y; Yoshimura K; Gomyo A; Hayakawa J; Kusuda M; Akahoshi Y; Ishihara Y; Kawamura K; Tanihara A; Sato M; Terasako-Saito K; Kameda K; Wada H; Kikuchi M; Kimura SI; Kako S; Kanda Y
Ann Hematol; 2018 Oct; 97(10):1951-1960. PubMed ID: 29860563
[TBL] [Abstract][Full Text] [Related]
13. Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems.
MacMillan ML; Weisdorf DJ; Wagner JE; DeFor TE; Burns LJ; Ramsay NK; Davies SM; Blazar BR
Biol Blood Marrow Transplant; 2002; 8(7):387-94. PubMed ID: 12171485
[TBL] [Abstract][Full Text] [Related]
14. Combination Therapy with Inolimomab and Etanercept for Severe Steroid-Refractory Acute Graft-versus-Host Disease.
van Groningen LF; Liefferink AM; de Haan AF; Schaap NP; Donnelly JP; Blijlevens NM; van der Velden WJ
Biol Blood Marrow Transplant; 2016 Jan; 22(1):179-82. PubMed ID: 26386320
[TBL] [Abstract][Full Text] [Related]
15. Late Gastrointestinal Complications of Allogeneic Hematopoietic Stem Cell Transplantation in Adults.
Sung AD; Hassan S; Cardona DM; Wild D; Nichols KR; Mehdikhani H; Balmadrid B; Detweiler CJ; Shealy M; Cirrincione C; Li Z; Poleski M; Dalton TE; Siamakpour-Reihani S; Chao NJ; Sullivan KM
Biol Blood Marrow Transplant; 2018 Apr; 24(4):734-740. PubMed ID: 29246821
[TBL] [Abstract][Full Text] [Related]
16. Treatment of graft versus host disease with mesenchymal stromal cells: a phase I study on 40 adult and pediatric patients.
Introna M; Lucchini G; Dander E; Galimberti S; Rovelli A; Balduzzi A; Longoni D; Pavan F; Masciocchi F; Algarotti A; Micò C; Grassi A; Deola S; Cavattoni I; Gaipa G; Belotti D; Perseghin P; Parma M; Pogliani E; Golay J; Pedrini O; Capelli C; Cortelazzo S; D'Amico G; Biondi A; Rambaldi A; Biagi E
Biol Blood Marrow Transplant; 2014 Mar; 20(3):375-81. PubMed ID: 24321746
[TBL] [Abstract][Full Text] [Related]
17. The association between acute graft-versus-host disease and antimicrobial peptide expression in the gastrointestinal tract after allogeneic stem cell transplantation.
Weber D; Frauenschläger K; Ghimire S; Peter K; Panzer I; Hiergeist A; Weber M; Kutny D; Wolff D; Grube M; Huber E; Oefner P; Gessner A; Hehlgans T; Herr W; Holler E
PLoS One; 2017; 12(9):e0185265. PubMed ID: 28934349
[TBL] [Abstract][Full Text] [Related]
18. The association between the incidence of intestinal graft-vs-host disease and antibiotic use after allogeneic hematopoietic stem cell transplantation.
Hidaka D; Hayase E; Shiratori S; Hasegawa Y; Ishio T; Tateno T; Okada K; Goto H; Sugita J; Onozawa M; Nakagawa M; Kahata K; Endo T; Hashimoto D; Teshima T
Clin Transplant; 2018 Sep; 32(9):e13361. PubMed ID: 30054935
[TBL] [Abstract][Full Text] [Related]
19. Diverting Enterostomy Improves Overall Survival of Patients With Severe Steroid-refractory Gastrointestinal Acute Graft-Versus-Host Disease.
Khodr J; Zerbib P; Rogosnitzky M; Magro L; Truant S; Yakoub-Agha I; Duhamel A; Seguy D
Ann Surg; 2021 Nov; 274(5):773-779. PubMed ID: 34342300
[TBL] [Abstract][Full Text] [Related]
20. Failure-free survival after initial systemic treatment of chronic graft-versus-host disease.
Inamoto Y; Flowers ME; Sandmaier BM; Aki SZ; Carpenter PA; Lee SJ; Storer BE; Martin PJ
Blood; 2014 Aug; 124(8):1363-71. PubMed ID: 24876566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
